<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="79ba021e-183c-4b4d-822e-4ff5ef54ca61"><labelDrug name="Nitrostat"><Normalization><mmtx cui="C0699241" preferredWord="Nitrostat" semType="phsu, orch"/></Normalization></labelDrug><generic name="nitroglycerin"/><sentence id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1" text="Drug Label for drug brand Nitrostat, containing nitroglycerin." type="negative"><entity charOffset="26:35" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.0" text="nitrostat" type="Biomedical_Entity"><Normalization><mmtx cui="C0699241" phraseText="Drug Label for drug brand Nitrostat," preferredWord="Nitrostat" semType="phsu, orch"/><RxNorm RxCui="202525"/></Normalization></entity><entity charOffset="48:61" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.1" text="nitroglycerin" type="Biomedical_Entity"><Normalization><mmtx cui="C0017887" phraseText="nitroglycerin." preferredWord="Nitroglycerin" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Nitrostat," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.0" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.1"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.0"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.1.e.1"/></sentence><sentence biomedicalEntities="6" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6" lineNumber="9" text="Administration of NITROSTAT is contraindicated in patients who are using a phosphodiesterase-5 (PDE-5) inhibitor (e.g., sildenafil citrate, tadalafil, vardenafil hydrochloride) since these compounds have been shown to potentiate the hypotensive effects of organic nitrates." type="regular"><anaphoraRelation><anaphoraEntity charOffset="183:198" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.12" text="these compounds" type="Expression"/><antecedentEntity charOffset="75-112" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1" text="phosphodiesterase-5 (PDE-5) inhibitor" type="Drug_Class"/></anaphoraRelation><entity charOffset="75:112" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1" text="phosphodiesterase-5 (PDE-5) inhibitor" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="a phosphodiesterase-5 (PDE-5) inhibitor" preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><mmtx cui="C2923059" phraseText="a phosphodiesterase-5 (PDE-5) inhibitor" preferredWord="Phosphodiesterase 5 Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="230032"/></Normalization></entity><entity charOffset="120:138" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.2" text="sildenafil citrate" type="Drug"><Normalization><mmtx cui="C0724693" phraseText="sildenafil citrate," preferredWord="Sildenafil citrate" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="140:149" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.4" text="tadalafil" type="Drug"><Normalization><mmtx cui="C1176316" phraseText="tadalafil," preferredWord="tadalafil" semType="phsu, orch"/><RxNorm RxCui="358263"/></Normalization></entity><entity charOffset="151:175" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.6" text="vardenafil hydrochloride" type="Drug"><Normalization><mmtx cui="C0972333" phraseText="vardenafil hydrochloride" preferredWord="Vardenafil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1309396"/></Normalization></entity><entity charOffset="31:46" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.8" text="contraindicated" type="Caution_Interaction"/><entity charOffset="31:46" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.9" text="contraindicated" type="SPAN"/><entity charOffset="18:27" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.10" text="NITROSTAT" type="Drug"><Normalization><mmtx cui="C0699241" phraseText="Administration of NITROSTAT" preferredWord="Nitrostat" semType="phsu, orch"/><RxNorm RxCui="202525"/></Normalization></entity><entity charOffset="218:252" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.14" text="potentiate the hypotensive effects" type="Specific_Interaction"/><entity charOffset="256:272" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.15" text="organic nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="1427579"/></Normalization></entity><drugClassMembership drug="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.2" drugClass="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1"/><drugClassMembership drug="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.4" drugClass="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1"/><drugClassMembership drug="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.6" drugClass="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1"/><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.8"><relations><relation type="hasSeverity"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.ddi.2"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.14"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.12"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.15"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.10" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.1" severity="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.9" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.8" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.12" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.15" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.6.e.14" type="Specific_Interaction"/></sentence><sentence id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.22" text="Several clinical trials of nitroglycerin patches or infusions in patients with angina pectoris have evaluated regimens that incorporated a 10- to 12-hour nitrate free interval. " type="negative"><entity charOffset="27:40" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.22.e.0" text="nitroglycerin" type="Biomedical_Entity"><Normalization><mmtx cui="C0017887" phraseText="Several clinical trials of nitroglycerin patches" preferredWord="Nitroglycerin" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="137:141" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.22.e.1" text="a 10" type="Biomedical_Entity"><Normalization><mmtx cui="C0052080" phraseText="a 10-" preferredWord="antineoplaston A10" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.22.e.0" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.22.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42" lineNumber="40" text="This effect may be more frequent in patients who have also consumed alcohol." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.41" Text="Treatment with nitroglycerin may be associated with lightheadedness upon standing, especially just after rising from a recumbent or seated position. "/><anaphoraEntity charOffset="5:11" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.e.1" text="effect" type="Expression"/><antecedentEntity charOffset="52:81" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.41.e.0" text="lightheadedness upon standing" type="SPAN"/></anaphoraRelation><entity charOffset="5:11" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.e.3" text="effect" type="Specific_Interaction"/><entity charOffset="68:75" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.e.4" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="also consumed alcohol." preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.41" text="Treatment with nitroglycerin may be associated with lightheadedness upon standing, especially just after rising from a recumbent or seated position. "><entity charOffset="15:28" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.41.e.1" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Treatment with nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Treatment with nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.42.e.4"/></sentence><sentence biomedicalEntities="4" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45" lineNumber="45" text="Patients receiving antihypertensive drugs, beta-adrenergic blockers, or phenothiazines and nitrates should be observed for possible additive hypotensive effects. " type="regular"><entity charOffset="132:160" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.1" text="additive hypotensive effects" type="Specific_Interaction"/><entity charOffset="72:86" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.2" text="phenothiazines" type="Drug_Class"><Normalization><mmtx cui="C0031434" phraseText="phenothiazines" preferredWord="phenothiazine" semType="phsu, orch"/><mmtx cui="C0031436" phraseText="phenothiazines" preferredWord="Phenothiazines" semType="phsu, orch"/><mmtx cui="C0304370" phraseText="phenothiazines" preferredWord="Phenothiazine derivatives" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="19:41" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.3" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="antihypertensive drugs," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="91:99" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.4" text="nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="202927"/></Normalization></entity><entity charOffset="43:67" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.5" text="beta-adrenergic blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.4" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.4" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.5" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.4" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.2"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.5" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.2"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.45.e.5"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46" lineNumber="45" text="Marked orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used concomitantly." type="regular"><entity charOffset="7:30" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.1" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="Marked orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="54:78" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.2" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="83:99" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.3" text="organic nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="1427579"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.3" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.46.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47" lineNumber="46" text="Concomitant use of nitrates and alcohol may cause hypotension." type="regular"><entity charOffset="50:61" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="19:27" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.2" text="nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="202927"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.3" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="alcohol" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.1"><relations><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.3" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.47.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48" lineNumber="47" text="The vasodilatory and hemodynamic effects of nitroglycerin may be enhanced by concomitant administration of aspirin." type="regular"><entity charOffset="4:16|33:40|65:73" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.1" text="vasodilatory effects enhanced" type="Specific_Interaction"/><entity charOffset="107:114" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="enhanced by concomitant administration of aspirin." preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="44:57" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.3" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="hemodynamic effects of nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="hemodynamic effects of nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="21:40|65:73" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.5" text="hemodynamic effects enhanced" type="Specific_Interaction"/><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.ddi.2"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.2" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.48.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49" lineNumber="48" text="Intravenous administration of nitroglycerin decreases the thrombolytic effect of alteplase. " type="regular"><entity charOffset="44:77" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.1" text="decreases the thrombolytic effect" type="Specific_Interaction"/><entity charOffset="81:90" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.2" text="alteplase" type="Drug"><Normalization><mmtx cui="C0032143" phraseText="the thrombolytic effect of alteplase." preferredWord="Alteplase" semType="phsu, aapp, enzy"/><RxNorm RxCui="8410"/></Normalization></entity><entity charOffset="0:43" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.3" text="Intravenous administration of nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Intravenous administration of nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Intravenous administration of nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.2" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.49.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50" lineNumber="48" text="Therefore, caution should be observed in patients receiving sublingual nitroglycerin during alteplase therapy." type="regular"><entity charOffset="11:18" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.1" text="caution" type="Caution_Interaction"/><entity charOffset="60:84" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.2" text="sublingual nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="sublingual nitroglycerin during alteplase therapy." preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="sublingual nitroglycerin during alteplase therapy." preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="92:101" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.3" text="alteplase" type="Drug"><Normalization><mmtx cui="C0032143" phraseText="sublingual nitroglycerin during alteplase therapy." preferredWord="Alteplase" semType="phsu, aapp, enzy"/><mmtx cui="C0032143" phraseText="sublingual nitroglycerin during alteplase therapy." preferredWord="Alteplase" semType="phsu, aapp, enzy"/><RxNorm RxCui="8410"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.1"><relations><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.3" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.50.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51" lineNumber="49" text="Intravenous nitroglycerin reduces the anticoagulant effect of heparin and activated partial thromboplastin times (APTT) should be monitored in patients receiving heparin and intravenous nitroglycerin. " type="regular"><entity charOffset="26:58" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.1" text="reduces the anticoagulant effect" type="Specific_Interaction"/><entity charOffset="62:69" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.2" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="the anticoagulant effect of heparin" preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="the anticoagulant effect of heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="0:25" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.3" text="Intravenous nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Intravenous nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Intravenous nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="130:139" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.5" text="monitored" type="Caution_Interaction"/><entity charOffset="162:169" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.6" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin" preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="174:199" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.7" text="intravenous nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="intravenous nitroglycerin." preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="intravenous nitroglycerin." preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.ddi.2"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.2" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.6" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.7" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.51.e.5" type="Caution_Interaction"/></sentence><sentence id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53" text="Tricyclic antidepressants (amitriptyline, desipramine, doxepin, others) and anticholinergic drugs may cause dry mouth and diminished salivary secretions. " type="negative"><entity charOffset="76:97" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.0" text="anticholinergic drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0242896" phraseText="anticholinergic drugs" preferredWord="Anticholinergic Agents" semType="phsu"/><RxNorm RxCui="1449194"/></Normalization></entity><entity charOffset="0:25" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.1" text="tricyclic antidepressants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003290" phraseText="Tricyclic antidepressants" preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="27:40" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.2" text="amitriptyline" type="Biomedical_Entity"><Normalization><mmtx cui="C0002600" phraseText="(amitriptyline," preferredWord="Amitriptyline" semType="phsu, orch"/><RxNorm RxCui="704"/></Normalization></entity><entity charOffset="55:62" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.3" text="doxepin" type="Biomedical_Entity"><Normalization><mmtx cui="C0013085" phraseText="doxepin," preferredWord="Doxepin" semType="phsu, orch"/><RxNorm RxCui="203179"/></Normalization></entity><entity charOffset="42:53" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.4" text="desipramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0011685" phraseText="desipramine," preferredWord="Desipramine" semType="phsu, orch"/><RxNorm RxCui="3247"/></Normalization></entity><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.1" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.0"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.0"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.0"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.4" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.0"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.1" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.2"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.1" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.3"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.1" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.4"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.3"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.4"/><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.4" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.53.e.3"/></sentence><sentence id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.55" text="Increasing salivation with chewing gum or artificial saliva products may prove useful in aiding dissolution of sublingual nitroglycerin." type="negative"><entity charOffset="122:135" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.55.e.0" text="nitroglycerin" type="Biomedical_Entity"><Normalization><mmtx cui="C0017887" phraseText="useful in aiding dissolution of sublingual nitroglycerin." preferredWord="Nitroglycerin" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="42:59" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.55.e.1" text="artificial saliva" type="Biomedical_Entity"><Normalization><mmtx cui="C0036088" phraseText="artificial saliva products" preferredWord="Artificial saliva" semType="phsu, bodm"/><RxNorm RxCui="9530"/></Normalization></entity><pair ddi="false" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.55.e.1" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.55.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56" lineNumber="51" text="Oral administration of nitroglycerin markedly decreases the first-pass metabolism of dihydroergotamine and subsequently increases its oral bioavailability. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="130:133" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.6" text="its" type="Expression"/><antecedentEntity charOffset="85-102" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.2" text="dihydroergotamine" type="Drug"/></anaphoraRelation><entity charOffset="46:81" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.1" text="decreases the first-pass metabolism" type="Increase_Interaction"/><entity charOffset="85:102" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.2" text="dihydroergotamine" type="Drug"><Normalization><mmtx cui="C0012291" phraseText="the first-pass metabolism of dihydroergotamine" preferredWord="Dihydroergotamine" semType="phsu, orch"/><RxNorm RxCui="3418"/></Normalization></entity><entity charOffset="0:36" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.3" text="Oral administration of nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Oral administration of nitroglycerin markedly" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Oral administration of nitroglycerin markedly" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="120:129|134:154" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.5" text="increases oral bioavailability" type="Increase_Interaction"/><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.1"><relations><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.ddi.2"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.5"><relations><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.2" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.3" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.6" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.56.e.5" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58" lineNumber="51" text="Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible." type="regular"><entity charOffset="62:67" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.1" text="avoid" type="Caution_Interaction"/><entity charOffset="30:54" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.2" text="sublingual nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="sublingual nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="sublingual nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="68:96" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.3" text="ergotamine and related drugs" type="Drug_Class"><Normalization><mmtx cui="C0014710" phraseText="ergotamine" preferredWord="Ergotamine" semType="phsu, orch"/><mmtx cui="C0013227" phraseText="related drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="4025"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.5" text="ergotism" type="Specific_Interaction"/><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.1"><relations><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.ddi.2"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.5"><relations><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.2" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.3" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.58.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59" lineNumber="52" text="Administration of nitroglycerin is contraindicated in patients who are using PDE-5 inhibitors (e.g., sildenafil citrate, tadalafil, vardenafil hydrochloride). " type="regular"><entity charOffset="35:50" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="35:50" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.2" text="contraindicated" type="SPAN"/><entity charOffset="77:93" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3" text="PDE-5 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="PDE-5 inhibitors" preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><RxNorm RxCui="1022271"/></Normalization></entity><entity charOffset="18:31" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.4" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Administration of nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Administration of nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="101:119" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.6" text="sildenafil citrate" type="Drug"><Normalization><mmtx cui="C0724693" phraseText="sildenafil citrate," preferredWord="Sildenafil citrate" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="121:130" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.8" text="tadalafil" type="Drug"><Normalization><mmtx cui="C1176316" phraseText="tadalafil," preferredWord="tadalafil" semType="phsu, orch"/><RxNorm RxCui="358263"/></Normalization></entity><entity charOffset="132:156" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.10" text="vardenafil hydrochloride" type="Drug"><Normalization><mmtx cui="C0972333" phraseText="vardenafil hydrochloride" preferredWord="Vardenafil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1309396"/></Normalization></entity><drugClassMembership drug="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.6" drugClass="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3"/><drugClassMembership drug="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.8" drugClass="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3"/><drugClassMembership drug="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.10" drugClass="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3"/><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.4" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3" severity="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.2" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60" lineNumber="52" text="These compounds have been shown to potentiate the hypotensive effects of organic nitrates." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59" Text="Administration of nitroglycerin is contraindicated in patients who are using PDE-5 inhibitors (e.g., sildenafil citrate, tadalafil, vardenafil hydrochloride). "/><anaphoraEntity charOffset="0:15" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.1" text="These compounds" type="Expression"/><antecedentEntity charOffset="77:93" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.59.e.3" text="PDE-5 inhibitors" type="Drug_Class"/></anaphoraRelation><entity charOffset="35:69" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.3" text="potentiate the hypotensive effects" type="Specific_Interaction"/><entity charOffset="73:89" id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.4" text="organic nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="1427579"/></Normalization></entity><drugInteraction id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.ddi.1"><interaction trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.1" e2="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.4" trigger="Dailymed.79ba021e-183c-4b4d-822e-4ff5ef54ca61.s.60.e.3" type="Specific_Interaction"/></sentence><positiveExamples number="18"/><negativeExamples number="18"/></document>